Aqua Bio Technology ASA (Oslo Axess: ABT) today announced its financial calendar for 2014.
Key dates are:
Q4 2013 reporting: 12 February 2014
Q1 2014 reporting: 21 May 2014
Q2 2014 reporting: 20 August 2014
Q3 2014 reporting: 26 November 2014
Q4 2014 reporting: 11 February 2015
Publishing of 2013 annual report: 9 April 2014
Annual General Meeting: 11 June 2014
For further information, please call Arvid Lindberg, CEO, telephone +47 9824 5410
Aqua Bio Technology ASA (ABT) develops, produces and markets patented ingredients and technologies to the international cosmetic and skin care industry. ABT's ingredients Aquabeautine XL, Dermaclarine and Beauty Propelline are marine solutions derived from the hatching fluid of salmon, while Oceanx Oil in Serum is based on extract from seaweed. ABT is listed on the Oslo Stock Exchange's Axess market.
